Lacosamide: Phase III data

In an open-label Phase III trial in 101 epileptic patients, IV

Read the full 110 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE